-Source- The Federalist-
Some physicians in the United States are performing double mastectomies on healthy 13-year-old girls. The justification is gender dysphoria (“transgenderism”)—the girls now identify as boys and therefore want to look like boys.
Sometimes this dysphoria doesn’t appear until adolescence, and often little or no psychological evaluation is done to determine the underlying cause of the teenager’s desire to mutilate her body. But these doctors are willing to give her what she thinks she wants. And your federal tax money is paying for research to validate this gruesome treatment (see here and here).
Reasonable people would be mystified, if not repelled, by the statements and actions of a leading researcher into transgender treatment. In a study funded by a $5.7 million grant from the National Institutes of Health (NIH), researchers including Dr. Johanna Olson of Children’s Hospital Los Angeles are supposedly evaluating use of puberty blockers and cross-sex hormones on dysphoric children.
As I’ve written with a coauthor, however, the study is fundamentally skewed toward the conclusions transgender activists desire: it contains no control group of subjects who will be spared these drugs, and will expire after five years, long before many negative effects may surface.
These design flaws aren’t surprising. Olson dismisses the possibility that gender dysphoria could be caused by psychological disturbance, claiming the only “mental health issue” related to gender dysphoria “comes from the way that the outside world responds” to the confused youth. She states, as though from a medical basis, that gender-dysphoric youth will go through the “wrong puberty” unless she and her cohorts can medicate them early enough in their lives to “put them through the right puberty.”
What are the odds that someone with this mindset will find any serious downside to administering puberty blockers and potentially dangerous hormones? She minimizes if not ignores the physical and psychological risks. Read more
Comentarios